A new breed of drug middlemen are pushing an unusual cost-saving strategy that lets their employer clients tap a federal program meant for hospitals that serve the poor. The government program ...
A new Executive Order refocuses federal agency attention on making already-required price data easier to get and use – a ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...
The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...
GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending ...
Companies such as Rescription, MakoRx and Liviniti sell benefit plans giving employers steep discounts for costly ...
During the pandemic, hospitals expanded the amount of 340B revenue they took in by partnering with other pharmacies, and drug makers retaliated by limiting those partnerships.
As drug prices continue to soar ... Discount cards do not cover hospital visits, surgeries, or other medical services. Cannot be used with insurance: Consumers must choose between using their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback